查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球過敏注射市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按免疫療法、按適應症、按過敏原、按分銷管道、按地區
市場調查報告書
商品編碼
1398829

全球過敏注射市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按免疫療法、按適應症、按過敏原、按分銷管道、按地區

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 309 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球過敏注射劑市場經歷了顯著成長，預計將從 2024 年的約 26 億美元增長到 2031 年底的 62 億美元。

全球過敏注射市場正在經歷強勁成長，這主要是由於全球各種過敏的發生率不斷上升。 過敏性鼻炎 (AR)、非過敏性鼻炎 (NAR) 和非特異性鼻炎的中位盛行率分別為 29.4%、18.1% 和 12.0%，存在地區差異。 鼻炎發生率的增加，加上都市化文化、污染、不良飲食和飲酒，導致過敏反應迅速增加，包括食物過敏和皮膚過敏。 隨著生活方式的發展，過敏注射治療的需求不斷增加，這是市場擴張的驅動力。

此外，由於特殊療法和重組免疫療法的進步，市場正在不斷發展。 製造商正在積極尋求合併、收購、聯盟和合作夥伴關係，以擴大其產品組合、擴大客戶群並擴大其地理覆蓋範圍。

儘管市場成長前景廣闊，但仍面臨挑戰。 過敏注射的治療週期較長，長達3至5年，取決於過敏的性質和階段。 患者經常因年齡、健康狀況、地點或經濟限製而停止治療，阻礙了市場擴張。

此外，與過敏注射劑和片劑相關的副作用也導致了市場萎縮。 超過10%的患者會出現副作用，其中大多數是輕微到嚴重的局部反應，如口腔搔癢和喉嚨不適。

本報告調查了全球過敏注射劑市場，並按產品、免疫療法、適應症、過敏原、分銷渠道、地區和市場進入對市場進行了概述。它提供了有關競爭趨勢的信息公司。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2023年生產與貿易統計

第 4 章價格分析，2018-2023

第五章2018-2031 年全球過敏注射市場前景

  • 2018-2031 年全球過敏注射液市場前景（按產品、價值（百萬美元）和數量（單位））
  • 2018-2031 年全球過敏注射市場前景（按免疫療法分類）、價值（百萬美元）、數量（單位）
  • 2018-2031 年全球過敏注射液市場前景，依適應症、價值（百萬美元）、數量（單位）劃分
  • 2018-2031 年全球過敏注射市場前景（按過敏原劃分）、價值（百萬美元）、數量（單位）
  • 2018-2031 年全球過敏注射液市場前景（按分銷管道、價值（百萬美元）、數量（單位））
  • 2018-2031 年全球過敏注射劑市場前景（按地區、價值（百萬美元）、數量（單位））

第六章北美過敏注射液市場展望，2018-2031

第 7 章歐洲過敏注射劑市場前景，2018-2031

第 8 章亞太地區過敏注射劑市場展望，2018-2031

第 9 章拉丁美洲過敏注射劑市場展望，2018-2031

第10章中東及非洲過敏注射劑市場前景，2018-2031

第十一章競爭態勢

  • 按類型與免疫療法劃分的熱圖
  • 製造商和免疫療法的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Stallergenes Greer
    • Allergy Therapeutics
    • Aimmune Therapeutics
    • Anergis
    • Arrayit Corporation
    • Biomay AG
    • HAL Allergy Group
    • DBV Technologies

第12章附錄

簡介目錄

The global Allergy Shots Market is poised for substantial growth, propelling the market valuation from approximately US$ 2.6 billion in 2024 to an estimated US$ 6.2 billion by the end of 2031.

Driving Factors

The global Allergy Shots Market is experiencing robust growth, primarily attributed to the escalating incidence of various allergy types worldwide. Allergic rhinitis (AR), non-allergic rhinitis (NAR), and nonspecific rhinitis have shown median prevalence rates of 29.4%, 18.1%, and 12.0%, respectively, with variations by region. This increasing frequency of rhinitis, combined with the adoption of urbanized cultures, pollution, poor dietary habits, and alcohol use, has led to a surge in allergic reactions, including food and skin allergies. As lifestyles evolve, the demand for allergy shots treatments is rising, driving market expansion.

Moreover, the market continually evolves with advancements in specialized therapeutics and recombinant immunotherapies. Manufacturers are embracing mergers, acquisitions, collaborations, and partnerships to broaden their product portfolios, extend their client base, and expand their geographic reach.

Challenges and Barriers

Despite its promising growth, the Allergy Shots Market faces challenges. The treatment course for Allergy Shots is lengthy, lasting up to 3 to 5 years depending on the allergy's nature and stage. Patients often discontinue treatment midway due to age, health, location, or financial constraints, hindering market expansion.

Additionally, adverse side effects associated with allergy injections and tablets have contributed to a market decline. More than 10% of patients reported experiencing adverse reactions, with the majority being mild to severe local reactions such as oral pruritus or throat discomfort.

Country-wise Insights

  • United States: The U.S. market is booming due to increased investments by regional key players in advanced product development, offering user-friendly solutions with rapid results. For example, Moonlight Therapeutics received $1.9 million in funding for preclinical investigations and product development for peanut allergy treatment.
  • Germany: Germany is emerging as a lucrative market with a focus on increasing product launches. In September 2019, the introduction of ITULAZAX, an efficient sublingual Allergy Shots tablet for tree pollen allergy, marked a significant development.
  • Japan: Japan is becoming a prominent market driven by the increasing prevalence of allergic rhinitis, affecting 10-30% of individuals globally. The high sensitivity of pollen from trees and grass in the region necessitates effective allergy treatments.

Competitive Landscape

The Allergy Shots Market is marked by a consolidated landscape with a small number of significant market players. Leading companies such as Aimmune Therapeutics, Hollister Allergy, Leti Pharma, and Merck KGaA are driving market growth through strategies like mergers and acquisitions, expansion, new product development, and alliances.

Key Companies Covered

  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies
  • ALK Abello

Key Segments Covered in Allergy Shots Industry Research

Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
  • Others
    • Injections
    • Others

Immunotherapy:

  • Sublingual Immunotherapy (SLIT)
  • Subcutaneous Immunotherapy (SCIT)
    • Specific Immunotherapy
  • Others

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
      • House Dust Mites (HDM)
      • Mold
      • Animal Dander
      • Bee Venom
      • Cockroaches/Insects
      • Others

Distribution Channel:

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Allergy Shots Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume ('000 Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Allergy Shots Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Allergy Shots Market Outlook, 2018 - 2031

  • 5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SLIT Tablets
        • 5.1.1.1.1. Odactra
        • 5.1.1.1.2. Grastek
        • 5.1.1.1.3. Ragwitek
        • 5.1.1.1.4. Oralair
        • 5.1.1.1.5. Actair
        • 5.1.1.1.6. Others
      • 5.1.1.2. Oral
        • 5.1.1.2.1. Palforzia
        • 5.1.1.2.2. Others
      • 5.1.1.3. Injections
      • 5.1.1.4. Others
  • 5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Sublingual Immunotherapy (SLIT)
      • 5.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 5.2.1.2.1. Specific Immunotherapy
      • 5.2.1.3. Others
  • 5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Allergic Rhinitis
      • 5.3.1.2. Allergic Asthma
      • 5.3.1.3. Food Allergy
      • 5.3.1.4. Atopic Dermatitis
      • 5.3.1.5. Others
  • 5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pollens
        • 5.4.1.1.1. Grass Pollens
        • 5.4.1.1.2. Weed Pollens
        • 5.4.1.1.3. Tree Pollens
      • 5.4.1.2. House Dust Mites (HDM)
      • 5.4.1.3. Mold
      • 5.4.1.4. Animal Dander
      • 5.4.1.5. Bee Venom
      • 5.4.1.6. Cockroaches/Insects
      • 5.4.1.7. Others
  • 5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Institutional Sales
        • 5.5.1.1.1. Government Hospitals
        • 5.5.1.1.2. Semi-Government Hospitals
        • 5.5.1.1.3. Private Hospitals
      • 5.5.1.2. Retail Sales
        • 5.5.1.2.1. Retail Pharmacy
        • 5.5.1.2.2. Drug Stores
        • 5.5.1.2.3. Online Pharmacy
  • 5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.6.1. Key Highlights
      • 5.6.1.1. North America
      • 5.6.1.2. Europe
      • 5.6.1.3. Asia Pacific
      • 5.6.1.4. Latin America
      • 5.6.1.5. Middle East & Africa

6. North America Allergy Shots Market Outlook, 2018 - 2031

  • 6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SLIT Tablets
        • 6.1.1.1.1. Odactra
        • 6.1.1.1.2. Grastek
        • 6.1.1.1.3. Ragwitek
        • 6.1.1.1.4. Oralair
        • 6.1.1.1.5. Actair
        • 6.1.1.1.6. Others
      • 6.1.1.2. Oral
        • 6.1.1.2.1. Palforzia
        • 6.1.1.2.2. Others
      • 6.1.1.3. Injections
      • 6.1.1.4. Others
  • 6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Sublingual Immunotherapy (SLIT)
      • 6.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 6.2.1.2.1. Specific Immunotherapy
      • 6.2.1.3. Others
  • 6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Allergic Rhinitis
      • 6.3.1.2. Allergic Asthma
      • 6.3.1.3. Food Allergy
      • 6.3.1.4. Atopic Dermatitis
      • 6.3.1.5. Others
  • 6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pollens
        • 6.4.1.1.1. Grass Pollens
        • 6.4.1.1.2. Weed Pollens
        • 6.4.1.1.3. Tree Pollens
      • 6.4.1.2. House Dust Mites (HDM)
      • 6.4.1.3. Mold
      • 6.4.1.4. Animal Dander
      • 6.4.1.5. Bee Venom
      • 6.4.1.6. Cockroaches/Insects
      • 6.4.1.7. Others
  • 6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. Institutional Sales
        • 6.5.1.1.1. Government Hospitals
        • 6.5.1.1.2. Semi-Government Hospitals
        • 6.5.1.1.3. Private Hospitals
      • 6.5.1.2. Retail Sales
        • 6.5.1.2.1. Retail Pharmacy
        • 6.5.1.2.2. Drug Stores
        • 6.5.1.2.3. Online Pharmacy
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis
  • 6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1. Key Highlights
      • 6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Allergy Shots Market Outlook, 2018 - 2031

  • 7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SLIT Tablets
        • 7.1.1.1.1. Odactra
        • 7.1.1.1.2. Grastek
        • 7.1.1.1.3. Ragwitek
        • 7.1.1.1.4. Oralair
        • 7.1.1.1.5. Actair
        • 7.1.1.1.6. Others
      • 7.1.1.2. Oral
        • 7.1.1.2.1. Palforzia
        • 7.1.1.2.2. Others
      • 7.1.1.3. Injections
      • 7.1.1.4. Others
  • 7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Sublingual Immunotherapy (SLIT)
      • 7.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 7.2.1.2.1. Specific Immunotherapy
      • 7.2.1.3. Others
  • 7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Allergic Rhinitis
      • 7.3.1.2. Allergic Asthma
      • 7.3.1.3. Food Allergy
      • 7.3.1.4. Atopic Dermatitis
      • 7.3.1.5. Others
  • 7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pollens
        • 7.4.1.1.1. Grass Pollens
        • 7.4.1.1.2. Weed Pollens
        • 7.4.1.1.3. Tree Pollens
      • 7.4.1.2. House Dust Mites (HDM)
      • 7.4.1.3. Mold
      • 7.4.1.4. Animal Dander
      • 7.4.1.5. Bee Venom
      • 7.4.1.6. Cockroaches/Insects
      • 7.4.1.7. Others
  • 7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Institutional Sales
        • 7.5.1.1.1. Government Hospitals
        • 7.5.1.1.2. Semi-Government Hospitals
        • 7.5.1.1.3. Private Hospitals
      • 7.5.1.2. Retail Sales
        • 7.5.1.2.1. Retail Pharmacy
        • 7.5.1.2.2. Drug Stores
        • 7.5.1.2.3. Online Pharmacy
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis
  • 7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1. Key Highlights
      • 7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.11. France Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Allergy Shots Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SLIT Tablets
        • 8.1.1.1.1. Odactra
        • 8.1.1.1.2. Grastek
        • 8.1.1.1.3. Ragwitek
        • 8.1.1.1.4. Oralair
        • 8.1.1.1.5. Actair
        • 8.1.1.1.6. Others
      • 8.1.1.2. Oral
        • 8.1.1.2.1. Palforzia
        • 8.1.1.2.2. Others
      • 8.1.1.3. Injections
      • 8.1.1.4. Others
  • 8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Sublingual Immunotherapy (SLIT)
      • 8.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 8.2.1.2.1. Specific Immunotherapy
      • 8.2.1.3. Others
  • 8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Allergic Rhinitis
      • 8.3.1.2. Allergic Asthma
      • 8.3.1.3. Food Allergy
      • 8.3.1.4. Atopic Dermatitis
      • 8.3.1.5. Others
  • 8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pollens
        • 8.4.1.1.1. Grass Pollens
        • 8.4.1.1.2. Weed Pollens
        • 8.4.1.1.3. Tree Pollens
      • 8.4.1.2. House Dust Mites (HDM)
      • 8.4.1.3. Mold
      • 8.4.1.4. Animal Dander
      • 8.4.1.5. Bee Venom
      • 8.4.1.6. Cockroaches/Insects
      • 8.4.1.7. Others
  • 8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. Institutional Sales
        • 8.5.1.1.1. Government Hospitals
        • 8.5.1.1.2. Semi-Government Hospitals
        • 8.5.1.1.3. Private Hospitals
      • 8.5.1.2. Retail Sales
        • 8.5.1.2.1. Retail Pharmacy
        • 8.5.1.2.2. Drug Stores
        • 8.5.1.2.3. Online Pharmacy
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis
  • 8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1. Key Highlights
      • 8.6.1.1. China Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.16. India Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Allergy Shots Market Outlook, 2018 - 2031

  • 9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. SLIT Tablets
        • 9.1.1.1.1. Odactra
        • 9.1.1.1.2. Grastek
        • 9.1.1.1.3. Ragwitek
        • 9.1.1.1.4. Oralair
        • 9.1.1.1.5. Actair
        • 9.1.1.1.6. Others
      • 9.1.1.2. Oral
        • 9.1.1.2.1. Palforzia
        • 9.1.1.2.2. Others
      • 9.1.1.3. Injections
      • 9.1.1.4. Others
  • 9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Sublingual Immunotherapy (SLIT)
      • 9.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 9.2.1.2.1. Specific Immunotherapy
      • 9.2.1.3. Others
  • 9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Allergic Rhinitis
      • 9.3.1.2. Allergic Asthma
      • 9.3.1.3. Food Allergy
      • 9.3.1.4. Atopic Dermatitis
      • 9.3.1.5. Others
  • 9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Pollens
        • 9.4.1.1.1. Grass Pollens
        • 9.4.1.1.2. Weed Pollens
        • 9.4.1.1.3. Tree Pollens
      • 9.4.1.2. House Dust Mites (HDM)
      • 9.4.1.3. Mold
      • 9.4.1.4. Animal Dander
      • 9.4.1.5. Bee Venom
      • 9.4.1.6. Cockroaches/Insects
      • 9.4.1.7. Others
  • 9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.5.1. Key Highlights
      • 9.5.1.1. Institutional Sales
        • 9.5.1.1.1. Government Hospitals
        • 9.5.1.1.2. Semi-Government Hospitals
        • 9.5.1.1.3. Private Hospitals
      • 9.5.1.2. Retail Sales
        • 9.5.1.2.1. Retail Pharmacy
        • 9.5.1.2.2. Drug Stores
        • 9.5.1.2.3. Online Pharmacy
    • 9.5.2. BPS Analysis/Market Attractiveness Analysis
  • 9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1. Key Highlights
      • 9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Allergy Shots Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. SLIT Tablets
        • 10.1.1.1.1. Odactra
        • 10.1.1.1.2. Grastek
        • 10.1.1.1.3. Ragwitek
        • 10.1.1.1.4. Oralair
        • 10.1.1.1.5. Actair
        • 10.1.1.1.6. Others
      • 10.1.1.2. Oral
        • 10.1.1.2.1. Palforzia
        • 10.1.1.2.2. Others
      • 10.1.1.3. Injections
      • 10.1.1.4. Others
  • 10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Sublingual Immunotherapy (SLIT)
      • 10.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 10.2.1.2.1. Specific Immunotherapy
      • 10.2.1.3. Others
  • 10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Allergic Rhinitis
      • 10.3.1.2. Allergic Asthma
      • 10.3.1.3. Food Allergy
      • 10.3.1.4. Atopic Dermatitis
      • 10.3.1.5. Others
  • 10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. Cell Wall Synthesis Inhibitors
      • 10.4.1.2. Protein Synthesis Inhibitors
      • 10.4.1.3. DNA Synthesis Inhibitors
      • 10.4.1.4. RNA Synthesis Inhibitors
      • 10.4.1.5. Others
  • 10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.5.1. Key Highlights
      • 10.5.1.1. Institutional Sales
        • 10.5.1.1.1. Government Hospitals
        • 10.5.1.1.2. Semi-Government Hospitals
        • 10.5.1.1.3. Private Hospitals
      • 10.5.1.2. Retail Sales
        • 10.5.1.2.1. Retail Pharmacy
        • 10.5.1.2.2. Drug Stores
        • 10.5.1.2.3. Online Pharmacy
    • 10.5.2. BPS Analysis/Market Attractiveness Analysis
  • 10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1. Key Highlights
      • 10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By Species vs by Immunotherapy Heat map
  • 11.2. Manufacturer vs by Immunotherapy Heat map
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Stallergenes Greer
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Allergy Therapeutics
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Aimmune Therapeutics
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Anergis
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Arrayit Corporation
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Biomay AG
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. HAL Allergy Group
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. DBV Technologies
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations